CRITIQUE OF METAANALYSIS OF 2ND-LINE ANTIRHEUMATIC DRUGS

[1] SECULAR CHANGES IN PUBLISHED CLINICAL-TRIALS OF 2ND-LINE AGENTS IN RHEUMATOID-ARTHRITIS [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (10): : 1304 - 1309

[2] PUBLICATION BIAS AND DISSEMINATION OF CLINICAL RESEARCH [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (02) : 107 - 115

[3] DAVIES J, 1984, CLIN RHEUMATOL, V3, P553, DOI 10.1007/BF02031283

[4] THE COMPARATIVE EFFICACY AND TOXICITY OF 2ND-LINE DRUGS IN RHEUMATOID-ARTHRITIS - RESULTS OF 2 METAANALYSES [J]. ARTHRITIS AND RHEUMATISM, 1990, 33 (10): : 1449 - 1461

[5] BIAS IN METAANALYTIC RESEARCH [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (08) : 885 - 892

[6] FELSON DT, 1993, ARTHRITIS RHEUM, V36, P1117

[7] METAANALYSIS OF 2ND-LINE ANTIRHEUMATIC DRUGS - SAMPLE-SIZE BIAS AND UNCERTAIN BENEFIT [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) : 587 - 594

[8] HEPBURN B, 1992, 2ND LINE AGENTS TREA, P145

[9] RHEUMATOID-ARTHRITIS - DISAPPOINTING LONG-TERM OUTCOMES DESPITE SUCCESSFUL SHORT-TERM CLINICAL-TRIALS [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (11) : 1037 - 1041

[10] PUBLICATION BIAS - THE CASE FOR AN INTERNATIONAL REGISTRY OF CLINICAL-TRIALS [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (10) : 1529 - 1541

[1] SECULAR CHANGES IN PUBLISHED CLINICAL-TRIALS OF 2ND-LINE AGENTS IN RHEUMATOID-ARTHRITIS [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (10): : 1304 - 1309

[2] PUBLICATION BIAS AND DISSEMINATION OF CLINICAL RESEARCH [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (02) : 107 - 115

[3] DAVIES J, 1984, CLIN RHEUMATOL, V3, P553, DOI 10.1007/BF02031283

[4] THE COMPARATIVE EFFICACY AND TOXICITY OF 2ND-LINE DRUGS IN RHEUMATOID-ARTHRITIS - RESULTS OF 2 METAANALYSES [J]. ARTHRITIS AND RHEUMATISM, 1990, 33 (10): : 1449 - 1461

[5] BIAS IN METAANALYTIC RESEARCH [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (08) : 885 - 892

[6] FELSON DT, 1993, ARTHRITIS RHEUM, V36, P1117

[7] METAANALYSIS OF 2ND-LINE ANTIRHEUMATIC DRUGS - SAMPLE-SIZE BIAS AND UNCERTAIN BENEFIT [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) : 587 - 594

[8] HEPBURN B, 1992, 2ND LINE AGENTS TREA, P145

[9] RHEUMATOID-ARTHRITIS - DISAPPOINTING LONG-TERM OUTCOMES DESPITE SUCCESSFUL SHORT-TERM CLINICAL-TRIALS [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (11) : 1037 - 1041

[10] PUBLICATION BIAS - THE CASE FOR AN INTERNATIONAL REGISTRY OF CLINICAL-TRIALS [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (10) : 1529 - 1541